Purchases and Sales Made in Q3 2021 in Eucrates Biomedical Acquisition Corp. (EUCRW)
This table provides information about the institutional ownership of Eucrates Biomedical Acquisition Corp. (EUCRW) during Q3 2021. The information is specifically focused on institutions that hold shares of Eucrates Biomedical Acquisition Corp..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2021
Q3 2021
|
Aqr Arbitrage LLC
Greenwich, CT |
BUY
|
- |
45.8KNew |
$442K - $458K
|
45.8K
$0
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.3KNew |
$12.5K - $13K
|
1.3K
$0
|
|
Nov 16, 2021
Q3 2021
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
40+ 0.15% |
$386 - $400
|
26.6K
$0
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
SELL
|
- |
-763- 39.37% |
$7.36K - $7.62K
|
1.18K
$0
|
|
Nov 10, 2021
Q3 2021
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-3.32KClosed |
$32K - $33.2K
|
0
$0
|
|
Oct 25, 2021
Q3 2021
|
Exos Asset Management LLC
New York, NY |
SELL
|
- |
-3.5KClosed |
$33.7K - $34.9K
|
0
$0
|
|
Oct 12, 2021
Q3 2021
|
Equitec Proprietary Markets, LLC
|
SELL
|
- |
-8.72KClosed |
$84.1K - $87.1K
|
0
$0
|